Jong‐Mu Sun
Impact in
- Oncology top 0.5%
- Cancer Immunotherapy and Biomarkers
- Lung Cancer Research Studies
- Pulmonary and Respiratory Medicine top 0.2%
- Lung Cancer Treatments and Mutations
- Lung Cancer Diagnosis and Treatment
- Brain Metastases and Treatment
Papers in
-
- Lung Cancer Treatments and Mutations 141
- Lung Cancer Diagnosis and Treatment 32
- Brain Metastases and Treatment 9
- Oncology 71
- Cancer Immunotherapy and Biomarkers 50
- Lung Cancer Research Studies 16
- Co-authors
- Myung‐Ju Ahn (223 shared papers)Keunchil Park (186 shared papers)Jin Seok Ahn (194 shared papers)Se‐Hoon Lee (125 shared papers)Yoon‐La Choi (58 shared papers)Hyun Ae Jung (81 shared papers)Bo Mi Ku (35 shared papers)Sung Hee Lim (22 shared papers)
- Journals
- Journal of Thoracic Oncology (38 papers)Lung Cancer (31 papers)Cancer Research and Treatment (24 papers)Cancer (11 papers)Annals of Oncology (10 papers)
- Partner nations
- South KoreaUnited StatesChina
In The Last Decade
Jong‐Mu Sun
299 papers receiving 13.5k citations
Jong‐Mu Sun's Hit Papers
Peers
Comparison fields: 5 of 107
- Oncology 4.5k
- Pulmonary and Respiratory Medicine 5.9k
- Otorhinolaryngology 355
- Cancer Research 787
- Surgery 1.8k
Countries citing papers authored by Jong‐Mu Sun
This map shows the geographic impact of Jong‐Mu Sun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jong‐Mu Sun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jong‐Mu Sun more than expected).
Fields of papers citing papers by Jong‐Mu Sun
This network shows the impact of papers produced by Jong‐Mu Sun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jong‐Mu Sun. The network helps show where Jong‐Mu Sun may publish in the future.
Co-authors
The 25 scholars most cited alongside Jong‐Mu Sun, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 303 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Pembrolizumab plus chemotherapy versus chemotherapy alone for first-line treatment of advanced oesophageal cancer (KEYNOTE-590): a randomised, placebo-controlled, phase 3 study Hit paper breakdown → | 2021 | 1140 |
| 2 | Single-cell RNA sequencing demonstrates the molecular and cellular reprogramming of metastatic lung adenocarcinoma Hit paper breakdown → | 2020 | 890 |
| 3 | Gemcitabine and oxaliplatin with or without erlotinib in advanced biliary-tract cancer: a multicentre, open-label, randomised, phase 3 study Hit paper breakdown → | 2011 | 395 |
| 4 | 2019 | 385 | |
| 5 | Osimertinib for Patients With Non–Small-Cell Lung Cancer Harboring Uncommon EGFR Mutations: A Multicenter, Open-Label, Phase II Trial (KCSG-LU15-09) Hit paper breakdown → | 2019 | 300 |
| 6 | 2018 | 261 | |
| 7 | Tislelizumab Versus Chemotherapy as Second-Line Treatment for Advanced or Metastatic Esophageal Squamous Cell Carcinoma (RATIONALE-302): A Randomized Phase III Study Hit paper breakdown → | 2022 | 226 |
| 8 | 2017 | 214 | |
| 9 | Artificial Intelligence–Powered Spatial Analysis of Tumor-Infiltrating Lymphocytes as Complementary Biomarker for Immune Checkpoint Inhibition in Non–Small-Cell Lung Cancer Hit paper breakdown → | 2022 | 211 |
| 10 | 2015 | 210 | |
| 11 | 2016 | 203 | |
| 12 | 2016 | 200 | |
| 13 | 2013 | 176 | |
| 14 | 2019 | 172 | |
| 15 | 2016 | 165 | |
| 16 | 2013 | 157 | |
| 17 | 2017 | 151 | |
| 18 | 2019 | 149 | |
| 19 | 2019 | 149 | |
| 20 | 2020 | 148 |
About Jong‐Mu Sun
Jong‐Mu Sun is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Otorhinolaryngology, Surgery and Cancer Research, having authored 303 papers that have together received 13.8k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (141 papers), Cancer Immunotherapy and Biomarkers (50 papers), Lung Cancer Diagnosis and Treatment (32 papers), Esophageal Cancer Research and Treatment (30 papers), Lung Cancer Research Studies (16 papers), Head and Neck Cancer Studies (15 papers), Brain Metastases and Treatment (9 papers) and Myasthenia Gravis and Thymoma (8 papers). The work is most often cited by research in Oncology (4.5k citations), Pulmonary and Respiratory Medicine (5.9k citations), Otorhinolaryngology (355 citations), Cancer Research (787 citations) and Surgery (1.8k citations). Jong‐Mu Sun has collaborated with scholars based in South Korea, United States and China. Frequent co-authors include Myung‐Ju Ahn, Keunchil Park, Jin Seok Ahn, Se‐Hoon Lee, Yoon‐La Choi, Hyun Ae Jung, Bo Mi Ku, Sung Hee Lim, Joungho Han and Yong Chan Ahn. Their work appears in journals such as Journal of Thoracic Oncology, Lung Cancer, Cancer Research and Treatment, Cancer and Annals of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.